Gordie Nye

Gordie Nye currently serves as the Chairman of the Board at LUUM since February 2024 and as a Senior Advisor at Oaklins DeSilva+Phillips from January 2022. Since January 2016, Gordie has been the Chairman of the Board of Managers at Journey Biosciences, Inc. Previous roles include Chief Executive Officer at Clear Intradermal Technologies, Inc. (June 2021 - July 2023) and Angel Medical Systems (July 2020 - June 2021), as well as Chairman of Atlantic Therapeutics (July 2017 - July 2020). Gordie founded R2 Dermatology, Inc. in December 2014 and served as CEO until July 2019. Earlier experience includes directorships at REVA Medical, Inc. (2001 - July 2017) and Systagenix Wound Management (2010 - 2013), alongside a tenure as CEO at Zeltiq Aesthetics (2009 - 2012). Gordie holds an AB in English from Dartmouth College and an MBA from The Tuck School of Business at Dartmouth.